About

Dr. Maria Monberg is the Scientific Strategy Director in the Pharma + Diagnostics Business Unit at DNAnexus, where she works with biopharma and diagnostics companies to apply genomic and clinical data toward drug development and precision oncology. She brings over a decade of experience spanning pharmaceutical R&D, clinical genomics, and real-world data strategy — most recently as part of the team that built and launched Translational360 at ConcertAI, now one of the largest commercial real-world data assets in oncology.

​

Dr. Monberg holds a PhD in translational cancer biology from MD Anderson Cancer Center, where her research in the Maitra Lab focused on treatment resistance in pancreatic cancer. She has a demonstrated track record of moving programs from early discovery through clinical trial introduction, and as a consultant with Ralph Porter Group, she advises organizations navigating the same complexity in precision oncology and genomic data strategy.

Jessica Monberg is a finance and operations professional with 7+ years of experience across FP&A, operational finance, and business strategy spanning hospitality, technology, and multi-site startups. Most recently serving as Finance and Accounting Manager at Montage International and previously as an FP&A Analyst at Flexera and COO of a four-location restaurant group, she has built a track record of translating complex financial data into clear, actionable insights for executive leadership.

​

Jessica holds a Master of Science in Finance from Indiana University's Kelley School of Business and a Bachelor of Science in Public Affairs with concentrations in HR Management and Finance from IU's O'Neill School. As a consultant with Ralph Porter Group, she works with organizations of all sizes on financial management, operations, marketing, and web development — with a growing focus on helping teams integrate AI tools to streamline workflows, improve decision-making, and scale with confidence.